OSSMAR: An Observational Study to Describe the Use of Sunitinib in Real-Life Practice for the Treatment of Metastatic Renal Cell Carcinoma

OSSMAR: An Observational Study to Describe the Use of Sunitinib in Real-Life Practice for the Treatment of Metastatic Renal Cell Carcinoma

PURPOSE: Sunitinib offers improved efficacy for patients with metastatic renal cell carcinoma (mRCC). To provide better disease management in the Middle East, we studied its use in mRCC in real-life practice in this region. MATERIAL AND METHODS: Patients diagnosed with mRCC and started on sunitinib...

Full description

Bibliographic Details
Main Authors: Marwan Ghosn, Roland Eid, Emad Hamada, Hamdy Abdel Azim, Jamal Zekri, Mubarak Al-Mansour, Mohammed Jaloudi, Fadi Nasr, Hassan Errihani, Adda Bounedjar, Amel Mezlini, Hamouda Boussen, Joseph Kattan, Fadi El Karak, Fadi Farhat, on behalf of the Africa Middle East Cancer Intergroup
Format: Article
Language:English
Published: American Society of Clinical Oncology 2019-10-01
Series:Journal of Global Oncology
Online Access:http://ascopubs.org/doi/10.1200/JGO.18.00238

Internet

http://ascopubs.org/doi/10.1200/JGO.18.00238

Similar Items